Application 022088

Type
NDA
Sponsor
PF PRISM CV

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TORISELTEMSIROLIMUSSOLUTION;INTRAVENOUS25MG/ML (25MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0008-1179ToriseltemsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-1179ToriseltemsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-1179ToriseltemsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-1179ToriseltemsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent
0008-1179ToriseltemsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
53505SUPPL2018-03-29
53504SUPPL2018-03-29
53466SUPPL2018-03-27
53465SUPPL2018-03-27
48515SUPPL2017-05-24
48512SUPPL2017-05-24
29228SUPPL2016-07-28
16926SUPPL2016-07-28
16925SUPPL2015-03-02
29227SUPPL2015-02-27
29226SUPPL2014-10-09
16924SUPPL2014-10-09
38215SUPPL2014-04-08
29225SUPPL2014-04-08
38214SUPPL2012-06-06
6861SUPPL2012-06-04
52362SUPPL2012-02-28
52361SUPPL2012-02-28
52360SUPPL2012-02-28
52359SUPPL2012-02-28
52358SUPPL2012-02-28
52357SUPPL2012-02-28
29224SUPPL2011-06-27
29223SUPPL2011-06-27
29222SUPPL2011-06-27
6860SUPPL2011-06-27
6858SUPPL2011-06-27
6856SUPPL2011-06-27
38213SUPPL2011-06-16
38212SUPPL2011-06-16
38211SUPPL2011-06-16
38210SUPPL2011-06-16
38209SUPPL2011-06-16
38208SUPPL2011-06-16
6859SUPPL2010-07-14
16923SUPPL2010-07-12
6857SUPPL2010-04-29
16922SUPPL2010-04-28
16921SUPPL2007-11-19
6855SUPPL2007-11-19
42411ORIG2007-07-30
16920ORIG2007-06-04
6854ORIG2007-06-04
53411ORIG1900-01-01
53410ORIG1900-01-01